Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-12-05
DOI
10.3389/fmicb.2017.02413
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults
- (2017) Scott A. Halperin et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
- (2017) Jason A. Regules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line
- (2016) L. Earnest-Silveira et al. JOURNAL OF GENERAL VIROLOGY
- Large scale production of a mammalian cell derived quadrivalent hepatitis C virus like particle vaccine
- (2016) L. Earnest-Silveira et al. JOURNAL OF VIROLOGICAL METHODS
- Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy
- (2016) Anuj Kumar et al. VACCINE
- Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States
- (2016) Elana S. Rosenthal et al. Infectious Agents and Cancer
- Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive Properties
- (2016) Elodie Beaumont et al. PLoS One
- Chimeric hepatitis B virus (HBV)/hepatitis C virus (HCV) subviral envelope particles induce efficient anti-HCV antibody production in animals pre-immunized with HBV vaccine
- (2015) Elodie Beaumont et al. VACCINE
- Expression, Purification and Immunogenic Description of a Hepatitis C Virus Recombinant CoreE1E2 Protein Expressed by Yeast Pichia pastoris
- (2015) Mehdi Fazlalipour et al. Jundishapur Journal of Microbiology
- Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses
- (2014) William O. Osburn et al. HEPATOLOGY
- Thirty years of baculovirus-insect cell protein expression: from dark horse to mainstream technology
- (2014) M. M. van Oers et al. JOURNAL OF GENERAL VIROLOGY
- Global epidemiology and genotype distribution of the hepatitis C virus infection
- (2014) Erin Gower et al. JOURNAL OF HEPATOLOGY
- Plant-based vaccines against viruses
- (2014) Edward P Rybicki Virology Journal
- Containing “The Great Houdini” of viruses: Combining direct acting antivirals with the host immune response for the treatment of chronic hepatitis C
- (2013) Gustaf Ahlén et al. DRUG RESISTANCE UPDATES
- Virus-like particle-based vaccines against hepatitis C virus infection
- (2013) Bertrand Bellier et al. Expert Review of Vaccines
- Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery
- (2013) Spyros A. Kalams et al. JOURNAL OF INFECTIOUS DISEASES
- Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine
- (2012) Elodie Beaumont et al. HEPATOLOGY
- Engineering of Papaya Mosaic Virus (PapMV) Nanoparticles through Fusion of the HA11 Peptide to Several Putative Surface-Exposed Sites
- (2012) Gervais Rioux et al. PLoS One
- Hepatitis C VLPs Delivered to Dendritic Cells by a TLR2 Targeting Lipopeptide Results in Enhanced Antibody and Cell-Mediated Responses
- (2012) Brendon Y. Chua et al. PLoS One
- Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
- (2012) Natasha Kushnir et al. VACCINE
- Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice
- (2012) Christophe Huret et al. VACCINE
- Vaccination for hepatitis C virus: closing in on an evasive target
- (2011) John Halliday et al. Expert Review of Vaccines
- Virus‑like particles as a vaccine delivery system: Myths and facts
- (2011) Polly Roy et al. Human vaccines & immunotherapeutics
- Large-scale production and purification of VLP-based vaccines
- (2011) Tiago Vicente et al. JOURNAL OF INVERTEBRATE PATHOLOGY
- A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques
- (2011) P. Garrone et al. Science Translational Medicine
- Construction and Immunological Evaluation of Multivalent Hepatitis B Virus (HBV) Core Virus-Like Particles Carrying HBV and HCV Epitopes
- (2010) I. Sominskaya et al. Clinical and Vaccine Immunology
- Characterization of hepatitis C virus pseudoparticles by cryo-transmission electron microscopy using functionalized magnetic nanobeads
- (2010) P. Bonnafous et al. JOURNAL OF GENERAL VIROLOGY
- A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection
- (2010) Wataru Akahata et al. NATURE MEDICINE
- Assembly of infectious hepatitis C virus particles
- (2010) Ralf Bartenschlager et al. TRENDS IN MICROBIOLOGY
- Challenges for the production of virus-like particles in insect cells: The case of rotavirus-like particles
- (2009) Laura A. Palomares et al. BIOCHEMICAL ENGINEERING JOURNAL
- Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development
- (2009) Delphine Desjardins et al. JOURNAL OF GENE MEDICINE
- Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies
- (2009) Romuald Patient et al. New Biotechnology
- DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies
- (2009) Bertrand Bellier et al. VACCINE
- Plants as biofactories
- (2008) Vadim Mett et al. BIOLOGICALS
- Recent progress in the development of plant derived vaccines
- (2008) Vidadi Yusibov et al. Expert Review of Vaccines
- Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain
- (2008) J. Bukh et al. JOURNAL OF VIROLOGY
- Influenza virus-like particles produced by transient expression inNicotiana benthamianainduce a protective immune response against a lethal viral challenge in mice
- (2008) Marc-André D’Aoust et al. PLANT BIOTECHNOLOGY JOURNAL
- An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles
- (2008) Luca Santi et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search